Bloodstream infections caused by ST2 Acinetobacter baumannii: risk factors, antibiotic regimens, and virulence over 6 years period in China
Abstract Background Bloodstream infection (BSI) caused by multidrug-resistant Acinetobacter baumannii (MDR-AB) has been increasingly observed among hospitalized patients. The following study analyzed the epidemiology and microbiological characteristics of MDR-AB, as well as the clinical features, an...
Main Authors: | Kaihang Yu, Weiliang Zeng, Ye Xu, Wenli Liao, Wenya Xu, Tieli Zhou, Jianming Cao, Lijiang Chen |
---|---|
Format: | Article |
Language: | English |
Published: |
BMC
2021-01-01
|
Series: | Antimicrobial Resistance and Infection Control |
Subjects: | |
Online Access: | https://doi.org/10.1186/s13756-020-00876-6 |
Similar Items
-
Retrospective comparative analysis of risk factors and outcomes in patients with carbapenem resistant Acinetobacter baumannii bloodstream infections: cefoperazone–sulbactam associated with resistance and tigecycline increased the mortality
by: Niu T, et al.
Published: (2018-10-01) -
Comparison of Tigecycline or Cefoperazone/Sulbactam therapy for bloodstream infection due to Carbapenem-resistant Acinetobacter baumannii
by: Tianshui Niu, et al.
Published: (2019-03-01) -
Sulbactam Enhances in vitro Activity of β-Lactam Antibiotics Against Acinetobacter baumannii
by: Wang L, et al.
Published: (2021-09-01) -
In vitro activity of cefoperazone and cefoperazone-sulbactam against carbapenem-resistant Acinetobacter baumannii and Pseudomonas aeruginosa
by: Lai CC, et al.
Published: (2018-12-01) -
Activity of Antimicrobial Combinations Against Extensively Drug-Resistant Acinetobacter baumannii as Determined by Checkerboard Method and E-test
by: Sunee Limsrivanichakorn, et al.
Published: (2020-03-01)